Kardigan, Inc.
Clinical trials sponsored by Kardigan, Inc., explained in plain language.
-
New drug aims to keep severe hypertension in check after hospital stay
Disease control Recruiting nowThis study tests an experimental drug called tonlamarsen in 100 adults recently hospitalized for dangerously high blood pressure. The goal is to see if it can lower blood pressure and reduce a protein linked to hypertension. Participants will receive either the drug or a placebo,…
Phase: PHASE2 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated May 26, 2026 08:49 UTC
-
New drug aims to halt heart valve narrowing without surgery
Disease control Recruiting nowThis study tests whether the drug ataciguat can slow the progression of moderate aortic valve stenosis, a condition where the heart's aortic valve becomes narrowed. About 1,276 adults aged 50 and older will receive either ataciguat or a placebo. The main goal is to see if the dru…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
New pill aims to strengthen weak hearts in genetic condition
Disease control Recruiting nowThis study tests an experimental daily pill, danicamtiv, in 332 people with genetic or familial dilated cardiomyopathy (a weakened, enlarged heart). Participants take the drug or a placebo for about 6 months to see if it improves heart function and exercise ability. The goal is t…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated May 18, 2026 11:59 UTC